News

Pharmabiz9h
CCRYN and NIMHANS ink MoU to advance mind body medicine research
CCRYN and NIMHANS ink MoU to advance mind body medicine research: Our Bureau, Bengaluru Tuesday, July 22, 2025, 17:15 Hrs ...
Pharmabiz10h
NIMHANS & University of Oslo unveil ‘PrecInNor’ an Indo-Norwegian initiative in precision psychiatry
NIMHANS & University of Oslo unveil ‘PrecInNor’ an Indo-Norwegian initiative in precision psychiatry: Our Bureau, Bengaluru ...
Pharmabiz8h
Voyager includes its wholly-owned Alzheimer’s disease programme to pipeline, complementing Tau and Amyloid assets with new APOE approach
Lexington, Massachusetts Tuesday, July 22, 2025, 18:00 Hrs [IST] ...
Pharmabiz9h
Ocugen doses first patient in phase 2/3 GARDian3 pivotal confirmatory trial of OCU410ST for Stargardt disease
Malvern, Pennsylvania Tuesday, July 22, 2025, 17:00 Hrs [IST] ...
Pharmabiz13h
Roche announces positive results from pivotal phase IIb ALIENTO & phase III ARNASA trials of astegolimab to treat COPD
Roche announces positive results from pivotal phase IIb ALIENTO & phase III ARNASA trials of astegolimab to treat COPD: Basel Tuesday, July 22, 2025, 13:00 Hrs [IST] Roche announc ...
Pharmabiz14h
US FDA accepts Bristol Myers Squibb’s sNDA for Sotyktu to treat adults with active psoriatic arthritis
Princeton, New Jersey Tuesday, July 22, 2025, 12:00 Hrs [IST] ...
Pharmabiz14h
Akums introduces high-strength paracetamol oral suspension 500mg/5ml to improve pain and fever management in adult and geriatric patients
Our Bureau, Mumbai Tuesday, July 22, 2025, 12:20 Hrs [IST] ...
Pharmabiz17h
Gonmisol enters strategic partnership with India-based K Patel Phyto Extractions to bring ayurvedic wellness to Europe
Gonmisol enters strategic partnership with India-based K Patel Phyto Extractions to bring ayurvedic wellness to Europe: Barcelona Tuesday, July 22, 2025, 09:00 Hrs [IST] Gonmisol ...
Pharmabiz10h
NICE recommends ALK’s tree pollen tablet, Itulazax for use in the UK health system
NICE recommends ALK’s tree pollen tablet, Itulazax for use in the UK health system: Hørsholm, Denmark Tuesday, July 22, 2025, 16:00 Hrs [IST] ALK, a global specialty pharmaceut ...
Pharmabiz16h
AstraZeneca announces positive results from FLAURA2 phase III trial of Tagrisso plus chemotherapy to treat EGFR-mutated advanced lung cancer
AstraZeneca announces positive results from FLAURA2 phase III trial of Tagrisso plus chemotherapy to treat EGFR-mutated advanced lung cancer: Cambridge, UK Tuesday, July 22, 2025, ...
Pharmabiz11h
Bizerba joins Körber’s PAS-X Weigh & Dispense programme as new partner
Bizerba joins Körber’s PAS-X Weigh & Dispense programme as new partner: Balingen, Germany Tuesday, July 22, 2025, 15:00 Hrs [IST] Bizerba, a global leader in industrial scales ...
Pharmabiz18h
FPME concerned over DCGI directive not allowing export of drugs labelled as ‘meant for sale in India’
The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has expressed concern over an office memorandum (OM) dated January 19, 2024 which directs all port officers and zonal/sub ...